Kassler-Taub Kenneth B. 4
4 · LEXICON PHARMACEUTICALS, INC. · Filed Feb 29, 2024
Insider Transaction Report
Form 4
Kassler-Taub Kenneth B.
SVP, Regulatory & QA
Transactions
- Exercise/Conversion
Common Stock
2024-02-28+27,556→ 154,268 total - Tax Payment
Common Stock
2024-02-28$2.62/sh−24,353$63,805→ 162,672 total - Exercise/Conversion
Restricted Stock Units
2024-02-28−7,087→ 0 total→ Common Stock (7,087 underlying) - Exercise/Conversion
Common Stock
2024-02-28+7,087→ 126,712 total - Exercise/Conversion
Common Stock
2024-02-28+32,757→ 187,025 total - Exercise/Conversion
Restricted Stock Units
2024-02-28−27,556→ 27,557 total→ Common Stock (27,556 underlying) - Exercise/Conversion
Restricted Stock Units
2024-02-28−32,757→ 65,513 total→ Common Stock (32,757 underlying)
Footnotes (3)
- [F1]Each restricted stock unit represents a contingent right to receive one share of common stock.
- [F2]Withholding of a portion of issued shares by the Company in satisfaction of shareholder's tax withholding obligations with respect thereto.
- [F3]Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant.